KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Amgen (AMGN) over the last 16 years, with Q4 2025 value amounting to 0.12%.

  • Amgen's Return on Invested Capital rose 300.0% to 0.12% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.12%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.12% for FY2025, which is 300.0% up from last year.
  • As of Q4 2025, Amgen's Return on Invested Capital stood at 0.12%, which was up 300.0% from 0.12% recorded in Q3 2025.
  • Amgen's 5-year Return on Invested Capital high stood at 0.21% for Q2 2022, and its period low was 0.08% during Q2 2024.
  • Over the past 5 years, Amgen's median Return on Invested Capital value was 0.12% (recorded in 2023), while the average stood at 0.14%.
  • Per our database at Business Quant, Amgen's Return on Invested Capital skyrocketed by 600bps in 2022 and then plummeted by -1000bps in 2023.
  • Over the past 5 years, Amgen's Return on Invested Capital (Quarter) stood at 0.16% in 2021, then increased by 28bps to 0.2% in 2022, then plummeted by -52bps to 0.1% in 2023, then fell by -1bps to 0.1% in 2024, then increased by 27bps to 0.12% in 2025.
  • Its Return on Invested Capital stands at 0.12% for Q4 2025, versus 0.12% for Q3 2025 and 0.11% for Q2 2025.